公司資料
Cyclerion 股價、新聞與催化劑
- 股票代碼:
- CYCN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
23.52 USD (+453.41%)
收盤價
最後更新: 2026年9月8日
13.1M USD
市值
股價為何變動
目前無法取得 CYCN 的收盤價變動背景。
公司概覽
業務概覽
Cyclerion was a biotechnology company focused on cyclic nucleotide biology and central nervous system or vascular-related disease programs before becoming a historical ticker. Its story reflected the challenge of turning a mechanistic platform into a durable drug franchise.
所在地與產業分類
Cyclerion was headquartered in the United States and traded on NASDAQ. It sat in the development-stage biotechnology segment.
商業模式特徵
The business depended on clinical validation, strategic focus, and capital efficiency. Investors historically watched whether the platform could produce differentiated medicines in a difficult field.
生技產業定位
Cyclerion belongs to the historical platform-biotech set. Like many early scientific names, its stock depended on data and the market's patience for development risk.
未來催化劑
- Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event. The market is mainly waiting for clarity on remaining value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。